DYMEF - Flow Capital Announces Legal Proceedings Against Dionymed

TORONTO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) (the “Company”) announced today that it has commenced legal proceedings against Dionymed Brands Inc. (CSE: DYME; OTCQB: DYMEF) (“DionyMed”) as DionyMed is in default under the Company’s royalty agreement.  The claim is for the minimum sum of $2,698,116 which is made up of the investment balance, past due royalty payments and late payment fees.  

The Company’s investment in DionyMed is $1,000,000 and there can be no assurance that the Company will recover any portion of its investment.

About Flow Capital

Flow Capital Corp. is a diversified alternative asset investor and advisor, specializing in providing minimally dilutive capital to emerging growth businesses. To apply for financing, visit www.flowcap.com.

For further information, please contact:

Flow Capital Corp.

Alex Baluta
Chief Executive Officer
alex@flowcap.com

1 Adelaide Street East, Suite 3002,

PO Box 171,

Toronto, Ontario M5C 2V9

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.